Biomoneta Receives US FDA Class II Clearance for Medical Air Cleaner

We are proud to announce that Biomoneta has become the first Indian company to receive US FDA 510(k) Class II clearance for a medical air-cleaning device. Our Avata Rx Medical Recirculating Air Cleaner, powered by our patented ZeBox® technology, has been cleared by the United States Food and Drug Administration for use in healthcare environments.

This milestone represents a significant validation of our science-led approach to airborne infection control. Unlike conventional air purification systems, ZeBox technology actively traps and neutralizes airborne microbes using advanced nanomaterials and controlled electric fields, delivering clinically proven performance without reliance on harmful chemicals or UV radiation.

The US FDA clearance enables us to expand the deployment of Avata Rx across hospitals and clinical settings in the United States, strengthening our mission to enhance patient safety and protect healthcare workers globally. This achievement reinforces our commitment to innovation, rigorous clinical validation, and setting new benchmarks in medical air decontamination.